CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma
Fordham, Ashleigh M, Xie, Jinhan, Gifford, Andrew J, Wadham, Carol, Morgan, Lisa T, Mould, Emily V A, Fadia, Mitali, Zhai, Lei, Massudi, Hassina, Ali, Zara S, Marshall, Glenn M, Lukeis, Robyn E, Fletcher, Jamie I, MacKenzie, Karen L, Trahair, Toby N
Published in British journal of cancer (01.09.2020)
Published in British journal of cancer (01.09.2020)
Get full text
Journal Article
Independent activation of CREB3L2 by glucose fills a regulatory gap in mouse β-cells by co-ordinating insulin biosynthesis with secretory granule formation
Sue, Nancy, Thai, Le May, Saito, Atsushi, Boyer, Cierra K, Fordham, Ashleigh M, Yan, Chenxu, Davenport, Aimee, Tao, Jiang, Bensellam, Mohammed, Cantley, James, Shi, Yan-Chuan, Stephens, Samuel B, Imaizumi, Kazunori, Biden, Trevor J
Published in Molecular metabolism (Germany) (01.01.2024)
Published in Molecular metabolism (Germany) (01.01.2024)
Get full text
Journal Article
Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells
Merlot, Angelica M, Sahni, Sumit, Lane, Darius J R, Fordham, Ashleigh M, Pantarat, Namfon, Hibbs, David E, Richardson, Vera, Doddareddy, Munikumar R, Ong, Jennifer A, Huang, Michael L H, Richardson, Des R, Kalinowski, Danuta S
Published in Oncotarget (30.04.2015)
Published in Oncotarget (30.04.2015)
Get full text
Journal Article
Abstract 4824: Targeting CD30 as a novel treatment strategy in RANBP2-ALK -rearranged inflammatory myofibroblastic tumor
Fordham, Ashleigh M., Blackburn, James, Heyer, Erin E., Xie, Jinhan, Mould, Emily V., Gifford, Andrew J., Morgan, Lisa T., Wadham, Carol, Fadia, Mitali, Fletcher, Jamie I., MacKenzie, Karen L., Trahair, Toby N.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article